sponsored
PatientsVille.com Logo

PatientsVille

Metformin and Lithium

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectMetforminLithium
BLOOD GLUCOSE INCREASED4.7% 0.5%
NAUSEA4.1% 2.3%
DIARRHOEA3.3% 1.5%
TREMOR0.7% 3.1%
TOXICITY TO VARIOUS AGENTS0.7% 3.1%
DRUG INEFFECTIVE2.9% 2.7%
DRUG INTERACTION0.9% 2.9%
WEIGHT DECREASED2.7% 0.9%
VOMITING2.5% 1.8%
FATIGUE2.4% 1.9%
WEIGHT INCREASED1% 2.3%
DIZZINESS2.1% 1.6%
DYSPNOEA2.1% 1.1%
INSOMNIA0.9% 2.1%
DEPRESSION0.7% 2.1%
LACTIC ACIDOSIS2% 0%
SOMNOLENCE0.8% 1.9%
HEADACHE1.8% 1.5%
ANXIETY0.8% 1.8%
CONFUSIONAL STATE0.8% 1.8%
MALAISE1.7% 1.3%
PAIN1.7% 1%
ASTHENIA1.6% 1.2%
DECREASED APPETITE1.6% 0.5%
ACUTE KIDNEY INJURY1.5% 0.6%
MANIA0% 1.5%
SUICIDAL IDEATION0% 1.5%
DIABETES MELLITUS0.9% 1.4%
OVERDOSE0.5% 1.4%
AGITATION0% 1.4%
FALL1.3% 1.2%
OFF LABEL USE1.1% 1.3%
PYREXIA0.8% 1.3%
COMPLETED SUICIDE0.6% 1.3%
FEELING ABNORMAL0.9% 1.2%
PAIN IN EXTREMITY1.2% 0.5%
HYPOGLYCAEMIA1.2% 0%
NEUROLEPTIC MALIGNANT SYNDROME0% 1.2%
SUICIDE ATTEMPT0% 1.2%
BLOOD GLUCOSE DECREASED1.2% 0%
DRUG DOSE OMISSION1.1% 0.8%
CONDITION AGGRAVATED0.7% 1.1%
ARTHRALGIA1.1% 0.5%
INJECTION SITE PAIN1.1% 0%
RASH1% 1%
PNEUMONIA1% 0.9%
HYPOTENSION1% 0.8%
GAIT DISTURBANCE0.7% 1%
DEATH1% 0.7%
RENAL FAILURE ACUTE1% 0.6%
ABDOMINAL PAIN1% 0.6%
PRURITUS1% 0.5%
MYOCARDIAL INFARCTION1% 0%
THERAPEUTIC AGENT TOXICITY0% 1%
HYPERTENSION0.9% 0.9%
DEHYDRATION0.9% 0.8%
RENAL FAILURE0.9% 0.7%
CHEST PAIN0.9% 0.6%
ABDOMINAL PAIN UPPER0.9% 0%
AGGRESSION0% 0.9%
DYSARTHRIA0% 0.9%
BIPOLAR DISORDER0% 0.9%
COUGH0.9% 0%
BACK PAIN0.9% 0%
CONSTIPATION0.8% 0.8%
MEMORY IMPAIRMENT0.5% 0.8%
PSYCHOTIC DISORDER0% 0.8%
TYPE 2 DIABETES MELLITUS0% 0.8%
SEDATION0% 0.8%
ANAEMIA0.8% 0%
HYPERHIDROSIS0.7% 0.7%
LOSS OF CONSCIOUSNESS0.5% 0.7%
ABNORMAL BEHAVIOUR0% 0.7%
DISORIENTATION0% 0.7%
IRRITABILITY0% 0.7%
GLYCOSYLATED HAEMOGLOBIN INCREASED0.7% 0%
URINARY TRACT INFECTION0.7% 0%
INCORRECT DOSE ADMINISTERED0.7% 0%
OEDEMA PERIPHERAL0.7% 0%
CEREBROVASCULAR ACCIDENT0.7% 0%
MUSCLE SPASMS0.7% 0%
ABDOMINAL DISCOMFORT0.7% 0%
MYALGIA0.7% 0%
VISION BLURRED0.5% 0.6%
BLOOD CREATININE INCREASED0.5% 0.6%
DYSKINESIA0% 0.6%
MENTAL DISORDER0% 0.6%
ANTIPSYCHOTIC DRUG LEVEL INCREASED0% 0.6%
EXTRAPYRAMIDAL DISORDER0% 0.6%
BALANCE DISORDER0% 0.6%
MENTAL STATUS CHANGES0% 0.6%
LETHARGY0% 0.6%
WHITE BLOOD CELL COUNT INCREASED0% 0.6%
AMNESIA0% 0.6%
CONVULSION0% 0.6%
SEROTONIN SYNDROME0% 0.6%
DELIRIUM0% 0.6%
DISTURBANCE IN ATTENTION0% 0.6%
HALLUCINATION0% 0.6%
TACHYCARDIA0% 0.6%
TARDIVE DYSKINESIA0% 0.6%
SPEECH DISORDER0% 0.6%
INJECTION SITE HAEMORRHAGE0.6% 0%
PARAESTHESIA0.6% 0%
ALOPECIA0.6% 0%
DIABETIC KETOACIDOSIS0.6% 0%
PANCREATITIS0.6% 0%
FLUSHING0.6% 0%
BLOOD PRESSURE INCREASED0.6% 0%
METABOLIC ACIDOSIS0.6% 0%
CARDIAC FAILURE CONGESTIVE0.6% 0%
RENAL IMPAIRMENT0.4% 0.5%
RESTLESSNESS0% 0.5%
BLOOD CHOLESTEROL INCREASED0% 0.5%
INTENTIONAL OVERDOSE0% 0.5%
COGNITIVE DISORDER0% 0.5%
NEPHROGENIC DIABETES INSIPIDUS0% 0.5%
TREATMENT NONCOMPLIANCE0% 0.5%
DEPRESSED LEVEL OF CONSCIOUSNESS0% 0.5%
DYSPHAGIA0% 0.5%
DRUG WITHDRAWAL SYNDROME0% 0.5%
COMA0% 0.5%
DRUG LEVEL INCREASED0% 0.5%
PARKINSONISM0% 0.5%
HYPOTHYROIDISM0% 0.5%
ELECTROCARDIOGRAM QT PROLONGED0% 0.5%
GASTROINTESTINAL HAEMORRHAGE0.5% 0%
ABDOMINAL DISTENSION0.5% 0%
DIABETES MELLITUS INADEQUATE CONTROL0.5% 0%
PERIPHERAL SWELLING0.5% 0%
MUSCULAR WEAKNESS0.5% 0%
ERYTHEMA0.5% 0%
SYNCOPE0.5% 0%
BLADDER CANCER0.5% 0%
HYPOAESTHESIA0.5% 0%
SEPSIS0.5% 0%
NASOPHARYNGITIS0.5% 0%
HYPERKALAEMIA0.5% 0%
DYSPEPSIA0.5% 0%
ATRIAL FIBRILLATION0.5% 0%
PRODUCT QUALITY ISSUE0.5% 0%
HYPERGLYCAEMIA0.5% 0%
DRUG HYPERSENSITIVITY0.5% 0%
HYPERSENSITIVITY0.4% 0%
URTICARIA0.4% 0%
HAEMOGLOBIN DECREASED0.4% 0%

New treatments are found every day. View current Metformin research studies and Lithium clinical trials

1